According to AC Immune's latest financial reports the company has a price-to-book ratio of 6.14694.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.74 | -32.54% |
2023-12-31 | 2.59 | 177.95% |
2022-12-31 | 0.9302 | -34.34% |
2021-12-31 | 1.42 | -6.9% |
2020-12-31 | 1.52 | -30.1% |
2019-12-31 | 2.18 | -38.43% |
2018-12-31 | 3.54 | -41.77% |
2017-12-31 | 6.07 | 18.03% |
2016-12-31 | 5.14 | |
2015-12-31 | N/A |